Amooru G. Damu
Cuddapah, AP 516005, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Quinazolinone Acrylamides as Multifunctional Anti-Alzheimer Agents: Unraveling their Modulating Efficacy on Amyloidogenic Peptide Assembly at the Molecular Level.
Journal: ACS chemical neuroscience
Published: April 02, 2025
Design, Synthesis, Characterization and In Vitro Evaluation of Anticholinesterase and Antioxidant Activities of Thiazole-Piperazine Sulphonamide Hybrids.
Journal: Chemistry & biodiversity
Published: February 16, 2025
Quinazolinone-Hydrazine Cyanoacetamide Hybrids as Potent Multitarget-Directed Druggable Therapeutics against Alzheimer's Disease: Design, Synthesis, and Biochemical, In Silico, and Mechanistic Analyses.
Journal: ACS chemical neuroscience
Published: September 05, 2024
Development of quinazolinone and vanillin acrylamide hybrids as multi-target directed ligands against Alzheimer's disease and mechanistic insights into their binding with acetylcholinesterase.
Journal: Journal of biomolecular structure & dynamics
Published: April 26, 2023
Synthesis and in vitro assessment of anticholinesterase and antioxidant properties of triazineamide derivatives.
Journal: Future medicinal chemistry
Published: December 20, 2022
Synthesis and anti-Alzheimer potential of novel α-amino phosphonate derivatives and probing their molecular interaction mechanism with acetylcholinesterase.
Journal: European journal of medicinal chemistry
Published: December 03, 2022
In-vitro evaluation of antioxidant and anticholinesterase activities of novel pyridine, quinoxaline and s-triazine derivatives.
Journal: Environmental research
Published: March 15, 2021
Targeting Natural Products for the Treatment of COVID-19 - An Updated Review.
Journal: Current pharmaceutical design
Published: June 15, 2020
Neuroblastoma and Stem Cell Therapy: An Updated Review.
Journal: CNS & neurological disorders drug targets
Published: May 06, 2020
New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer's Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase.
Journal: Molecular pharmaceutics
Published: May 11, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026